Skip to content
EntityQ5119890· pop 7· linked from 339 articles

ciglitazone

Sign in to save

Also known as (+-)-5-{p-[(1-Methylcyclohexyl)methoxy]benzyl}-2,4-thiazolidinedione

Ciglitazone (INN) is a thiazolidinedione. Developed by Takeda Pharmaceuticals in the early 1980s, it is considered the prototypical compound for the thiazolidinedione class.

Wikidata facts

Subclass of
glitazone
Mass
333.139865
Show 4 more facts
World Health Organisation international non-proprietary name
环格列酮
chemical formula
C₁₈H₂₃NO₃S
canonical SMILES
CC1(CCCCC1)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
subject has role
anti-diabetic medication
Sources (3)

via Wikidata · CC0

~2 min read

Encyclopedic overview

1 sections
Contents
  • References

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 404168235 | IUPAC_name = 5-{4-[(1-methylcyclohexyl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione | image = Ciglitazone.svg | image_class = skin-invert-image | width = 222

| tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

Excerpted from Wikipedia’s “ciglitazone” article, available under the CC BY-SA 4.0 licence.

Available in 7 languages

via Wikidata sitelinks · CC0